Analysis of DNA methylation status of IGFBP-1 and its association with serum IGFBP-1 levels in T2DM found that the DNA methylation levels of six CpG sites were higher in T2DM patients compared with the control individuals. The gene discussed is IGFBP1; the disease is type 2 diabetes mellitus.